Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""PARTONEN, T"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 66
Tytuł:
Long-term residential sunlight exposure associated with cognitive function among adults residing in Finland.
Autorzy:
Komulainen K; Department of Psychology and Logopedics, University of Helsinki, P.O. Box 21, 00014, Helsinki, Finland. .; Finnish Institute for Health and Welfare, Helsinki, Finland. .
Hakulinen C; Department of Psychology and Logopedics, University of Helsinki, P.O. Box 21, 00014, Helsinki, Finland.; Finnish Institute for Health and Welfare, Helsinki, Finland.
Lipsanen J; Department of Psychology and Logopedics, University of Helsinki, P.O. Box 21, 00014, Helsinki, Finland.
Partonen T; Finnish Institute for Health and Welfare, Helsinki, Finland.
Pulkki-Råback L; Department of Psychology and Logopedics, University of Helsinki, P.O. Box 21, 00014, Helsinki, Finland.
Kähönen M; Department of Clinical Physiology, Tampere University Hospital and Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Virtanen M; School of Educational Sciences and Psychology, University of Eastern Finland, Joensuu, Finland.; Division of Insurance Medicine, Karolinska Institutet, Stockholm, Sweden.
Ruuhela R; Weather and Climate Change Impact Research, Finnish Meteorological Institute, Helsinki, Finland.
Raitakari O; Centre for Population Health Research, University of Turku and Turku University Hospital, Turku, Finland.; Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.; Department of Clinical Physiology and Nuclear Medicine, Turku University Hospital, Turku, Finland.
Rovio S; Centre for Population Health Research, University of Turku and Turku University Hospital, Turku, Finland.; Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.
Elovainio M; Department of Psychology and Logopedics, University of Helsinki, P.O. Box 21, 00014, Helsinki, Finland.; Finnish Institute for Health and Welfare, Helsinki, Finland.; Research Program Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Dec 02; Vol. 12 (1), pp. 20818. Date of Electronic Publication: 2022 Dec 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Sunlight*
Cognition*
Adult ; Humans ; Finland/epidemiology ; Executive Function ; Memory
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The impact of Mendelian sleep and circadian genetic variants in a population setting.
Autorzy:
Weedon MN; Genetics of Complex Traits, College of Medicine and Health, University of Exeter, Exeter, Devon, United Kingdom.
Jones SE; Genetics of Complex Traits, College of Medicine and Health, University of Exeter, Exeter, Devon, United Kingdom.; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
Lane JM; Center for Genomic Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.; Broad Institute, Cambridge, Massachusetts, United States of America.; Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Lee J; Division of Sleep and Circadian Disorders, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Ollila HM; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.; Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America.; Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, United States of America.; Department of Psychiatry and Behavioral Sciences, School of Medicine, Stanford University, Stanford, California, United States of America.
Dawes A; Genetics of Complex Traits, College of Medicine and Health, University of Exeter, Exeter, Devon, United Kingdom.
Tyrrell J; Genetics of Complex Traits, College of Medicine and Health, University of Exeter, Exeter, Devon, United Kingdom.
Beaumont RN; Genetics of Complex Traits, College of Medicine and Health, University of Exeter, Exeter, Devon, United Kingdom.
Partonen T; Department of Public Health Solutions, Finnish Institute for Health and Welfare, Helsinki, Finland.
Merikanto I; Department of Public Health Solutions, Finnish Institute for Health and Welfare, Helsinki, Finland.; SleepWell Research Program Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Rich SS; Center for Public Health Genomics, Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia, United States of America.
Rotter JI; Institute for Genomics and Population Sciences, The Lundquist Institute for Biomedical Innovation, Torrance, California, United States of America.; Department of Pediatrics, Harbor-UCLA Medical Center, Torrance, California, United States of America.
Frayling TM; Genetics of Complex Traits, College of Medicine and Health, University of Exeter, Exeter, Devon, United Kingdom.
Rutter MK; Division of Diabetes, Endocrinology and Gastroenterology, Faculty of Medicine, Biology and Health, University of Manchester, Manchester, United Kingdom.; Diabetes, Endocrinology and Metabolism Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.
Redline S; Division of Sleep and Circadian Disorders, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Sofer T; Division of Sleep and Circadian Disorders, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Saxena R; Center for Genomic Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.; Broad Institute, Cambridge, Massachusetts, United States of America.; Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Wood AR; Genetics of Complex Traits, College of Medicine and Health, University of Exeter, Exeter, Devon, United Kingdom.
Pokaż więcej
Źródło:
PLoS genetics [PLoS Genet] 2022 Sep 22; Vol. 18 (9), pp. e1010356. Date of Electronic Publication: 2022 Sep 22 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Circadian Rhythm*/genetics
Sleep Wake Disorders*/genetics
Humans ; Phenotype ; Receptors, G-Protein-Coupled/genetics ; Sleep/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Neuropsychiatric Consequences of COVID-19 Pandemic: A Synthetic Review from a Global Perspective.
Autorzy:
Pandi-Perumal SR; Somnogen Canada Inc., College Street, Toronto, Canada.; Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India.
Zaki NFW; Sleep research unit, Department of Psychiatry, Faculty of Medicine, Mansoura University, Egypt.; Department of Psychiatry, North Area Armed Forces Hospital (NAAFH) KSA, Saudi Arabia.
Qasim M; Department of Rehabilitation Medicine, North Area -Armed Forces Hospital (NAAFH)-KSA, Saudi Arabia.
Elsayed Morsy N; Department of Chest Medicine, Faculty of Medicine, Mansoura University, Egypt.
Manzar MD; Department of Nursing, College of Applied Medical Sciences, Majmaah University, Majmaah, Saudi Arabia.
BaHammam AS; University Sleep Disorders Center, Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.; Strategic Technologies Program of the National Plan for Sciences and Technology and Innovation in the Kingdom of Saudi Arabia.
Jahrami H; College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Kingdom of Bahrain.; Ministry of Health, Manama, Kingdom of Bahrain.
Ramasubramanian C; Division of Community Psychiatry, M. S. Chellamuthu Trust and Research Foundation, Madurai, India.
Karthikeyan R; Independent Researcher, Narayanapuram, Madurai, Tamil Nadu, India.
Supasitthumrong T; Department of Psychiatry, Chulalongkorn University Faculty of Medicine, Bangkok, Thailand.
Moscovitch A; Department of Psychiatry, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada.
Trakht I; Department of Medicine, Columbia University, New York, NY, USA.
Gupta R; Department of Psychiatry, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
Narasimhan M; Department of Neuropsychiatry and Behavioral Science, Columbia, University of South Carolina, South Carolina, USA.; Department of Public Health and Welfare, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Partonen T; Department of Cell Systems and Anatomy, UT Health San Antonio, San Antonio, Texas USA.
Reiter RJ; The Institute for Mental and Physical Health and Clinical Translation Strategy Research Centre, Deakin University School of Medicine, Geelong Victoria, Australia.
Morris G; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
Berk M; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.; Department of Psychiatry, University of Melbourne, Parkville, Australia.; Orygen Youth Health Research Centre, Parkville, Australia.; Department of Psychiatry, University of Toronto, Canada.
Kennedy SH; SAMRC Unit on Risk & Resilience in Mental Disorders, Department of Psychiatry & Neuroscience Institute, University of Cape Town, South Africa.
Stein DJ; Neuroscience Education Institute, University of California San Diego, San Diego, CA, USA.
Stahl SM; Departments of Psychiatry, Neuroscience, and Pharmacological Sciences, Mount Sinai School of Medicine, New York, NY, USA.
Charney DS; Departments of Psychiatry, Neuroscience, and Pharmacological Sciences, Mount Sinai School of Medicine, New York, NY, USA.
Seeman MV; SAMRC Unit on Risk & Resilience in Mental Disorders, Department of Psychiatry & Neuroscience Institute, University of Cape Town, South Africa.
Pokaż więcej
Źródło:
Alpha psychiatry [Alpha Psychiatry] 2022 Jul 01; Vol. 23 (4), pp. 144-154. Date of Electronic Publication: 2022 Jul 01 (Print Publication: 2022).
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Alu element in the RNA binding motif protein, X-linked 2 (RBMX2) gene found to be linked to bipolar disorder.
Autorzy:
Laine P; Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
Rowell WJ; Pacific Biosciences, Menlo Park, CA, United States of America.
Paulin L; Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
Kujawa S; Pacific Biosciences, Menlo Park, CA, United States of America.
Raterman D; Roche Sequencing Solutions, Madison, WI, United States of America.
Mayhew G; Roche Sequencing Solutions, Madison, WI, United States of America.
Wendt J; Roche Sequencing Solutions, Madison, WI, United States of America.
Burgess DL; Roche Sequencing Solutions, Madison, WI, United States of America.
Partonen T; Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland.
Paunio T; Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland.; Department of Psychiatry, University of Helsinki, Helsinki, Finland.
Auvinen P; Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
Ekholm JM; Pacific Biosciences, Menlo Park, CA, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Dec 16; Vol. 16 (12), pp. e0261170. Date of Electronic Publication: 2021 Dec 16 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Alu Elements*
Genes, X-Linked*
Genetic Predisposition to Disease*
Bipolar Disorder/*genetics
Female ; Humans ; Male ; Pedigree
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Eveningness increases risks for depressive and anxiety symptoms and hospital treatments mediated by insufficient sleep in a population-based study of 18,039 adults.
Autorzy:
Merikanto I; Department of Public Health Solutions, Finnish Institute for Health and Welfare, Helsinki, Finland.; SleepWell Research Program Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Orton Orthopaedics Hospital, Helsinki, Finland.
Partonen T; Department of Public Health Solutions, Finnish Institute for Health and Welfare, Helsinki, Finland.
Pokaż więcej
Źródło:
Depression and anxiety [Depress Anxiety] 2021 Oct; Vol. 38 (10), pp. 1066-1077. Date of Electronic Publication: 2021 Jun 25.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Circadian Rhythm*
Sleep Deprivation*
Adult ; Anxiety ; Hospitals ; Humans ; Prospective Studies ; Sleep ; Surveys and Questionnaires
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Suicide prevention training: self-perceived competence among primary healthcare professionals.
Autorzy:
Solin P; Mental Health Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.
Tamminen N; Mental Health Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.
Partonen T; Mental Health Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.
Pokaż więcej
Źródło:
Scandinavian journal of primary health care [Scand J Prim Health Care] 2021 Sep; Vol. 39 (3), pp. 332-338. Date of Electronic Publication: 2021 Aug 03.
Typ publikacji:
Journal Article
MeSH Terms:
Suicide Prevention*
Attitude of Health Personnel ; Clinical Competence ; Health Personnel ; Humans ; Primary Health Care ; Suicidal Ideation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Data-driven modelling approach to circadian temperature rhythm profiles in free-living conditions.
Autorzy:
Lipsanen J; Sleepwell Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Kuula L; Sleepwell Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Elovainio M; Sleepwell Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Partonen T; Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland.
Pesonen AK; Sleepwell Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Jul 22; Vol. 11 (1), pp. 15029. Date of Electronic Publication: 2021 Jul 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Circadian Rhythm*
Models, Theoretical*
Temperature*
Algorithms ; Cluster Analysis ; Female ; Humans ; Male ; Self Report ; Sleep ; Sleep Disorders, Circadian Rhythm/epidemiology ; Sleep Disorders, Circadian Rhythm/etiology ; Surveys and Questionnaires
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Animal Welfare Attitudes: Effects of Gender and Diet in University Samples from 22 Countries.
Autorzy:
Randler C; Department of Biology, University of Tuebingen, Morgenstelle 24, D-72076 Tuebingen, Germany.; LEAD Graduate School and Research Network, University of Tübingen, D-72072 Tübingen, Germany.; Department of Biology, Faculty of Natural Sciences and Technology, University of Education Heidelberg, D-69120 Heidelberg, Germany.
Adan A; Department of Clinical Psychology and Psychobiology, School of Psychology, University of Barcelona, 08035 Barcelona, Spain.; Institute of Neurosciences, University of Barcelona, 08035 Barcelona, Spain.
Antofie MM; Faculty of Agricultural Sciences, Food Industry and Environmental Protection, 'Lucian Blaga' University of Sibiu, 550012 Sibiu, Romania.
Arrona-Palacios A; Writing Lab, Institute for the Future of Education, Tecnologico de Monterrey, 64849 Monterery, Mexico.
Candido M; Department of Natural Sciences, Universidade Pedagogica Mazombique, University Rovuma, 3100 Nampula, Mozambique.
Boeve-de Pauw J; Department of Training and Education Sciences, University of Antwerp, Prinsstraat 13, 2000 Antwerp, Belgium.
Chandrakar P; SoS in Life Science, Pt. Ravishankar Shukla University, Raipur 492010, India.
Demirhan E; Department of Special Education, Sakarya University, Sakarya 54300, Turkey.
Detsis V; Department of Economics and Sustainable Development, Harokopio University, Venizelou 70, 17676 Athens, Greece.
Di Milia L; School of Business & Law, CQ University Australia, Rockhampton, QLD 4701, Australia.
Fančovičová J; Department of Biology, Faculty of Education, Trnava University, Priemyselná 4, 918 43 Trnava, Slovakia.
Gericke N; Department of Environmental and Life Sciences, Karlstad University, 65188 Karlstad, Sweden.
Haldar P; Department of Biological Sciences, Midnapore City College, Paschim Medinipur 721129, West Bengal, India.
Heidari Z; Independent Researcher, 1653676331 Tehran, Iran.
Jankowski KS; Faculty of Psychology, University of Warsaw, 00-183 Warszawa, Poland.
Lehto JE; Educational Sciences, Open University, P.O. Box 9 (Siltavuorenpenger 3 A), University of Helsinki, 00014 Helsinki, Finland.
Lundell-Creagh R; Department of Psychology, Bishops University, Sherbrooke, QC J1M 1Z7, Canada.
Medina-Jerez W; College of Education, University of Texas at El Paso, El Paso, TX 79968, USA.
Meule A; Department of Psychiatry and Psychotherapy, University Hospital of the LMU Munich, Nußbaumstraße 7, 80336 Munich, Germany.; Schoen Clinic Roseneck, Am Roseneck 6, 83209 Prien am Chiemsee, Germany.
L Milfont T; School of Psychology, University of Waikato, 3240 Hamilton, New Zealand.
Orgilés M; Department of Health Psychology, Miguel Hernández University, 03202 Elche (Alicante), Spain.
Morales A; Department of Health Psychology, Miguel Hernández University, 03202 Elche (Alicante), Spain.
Natale V; Department of Psychology 'Renzo Canestrari', University of Bologna, Viale Berti Pichat 5, 40127 Bologna, Italy.
Ortiz-Jiménez X; School of Psychology, Autonomous University of Nuevo Leon, 64460 Monterrey, Mexico.
Pande B; SoS in Life Science, Pt. Ravishankar Shukla University, Raipur 492010, India.
Partonen T; Department of Public Health and Welfare, Finnish Institute for Health and Welfare (THL), P.O. Box 30 (Mannerheimintie 166), 00271 Helsinki, Finland.
Pati AK; SoS in Life Science, Pt. Ravishankar Shukla University, Raipur 492010, India.; Center for Translational Chronobiology, Pt. Ravishankar Shukla University, Raipur 492010, India.; Gangadhar Meher University, Sambalpur 768004, India.
Prokop P; Department of Environmental Ecology and Landscape Management, Faculty of Natural Sciences, Comenius University, Ilkovičova 6, 842 15 Bratislava, Slovakia.; Institute of Zoology, Slovak Academy of Sciences, Dúbravská cesta 9, 845 06 Bratislava, Slovakia.
Rahafar A; Independent Researcher, 1653676331 Tehran, Iran.
Scheuch M; Austrian Educational Competence Centre for Biology, University of Vienna, Porzellangasse 4/2, 1090 Vienna, Austria.; Environmental Education, University College for Agricultural & Environmental Education, Angermayergasse 1, 1130 Vienna, Austria.
Sahu S; Ergonomics & Occupational Physiology Laboratory, Department of Physiology, University of Kalyani, Kalyani 741235, West Bengal, India.
Tomažič I; Department of Biology, Biotechnical Faculty, University of Ljubljana, Večna pot 111, 1000 Ljubljana, Slovenia.
Tonetti L; Department of Psychology 'Renzo Canestrari', University of Bologna, Viale Berti Pichat 5, 40127 Bologna, Italy.
Vallejo Medina P; Fundación Universitaria Konrad Lorenz. Cra. 9 Bis #62-43, 110231 Bogotá, Colombia.
van Petegem P; Department of Training and Education Sciences, University of Antwerp, Prinsstraat 13, 2000 Antwerp, Belgium.
Vargas A; Fundación Universitaria Konrad Lorenz. Cra. 9 Bis #62-43, 110231 Bogotá, Colombia.
Vollmer C; Department of Research and Development in Teacher Education, University College of Teacher Education Tyrol, Pastorsstr. 7, 6020 Innsbruck, Austria.
Pokaż więcej
Źródło:
Animals : an open access journal from MDPI [Animals (Basel)] 2021 Jun 25; Vol. 11 (7). Date of Electronic Publication: 2021 Jun 25.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Nutrition-focused group intervention with a strength-based counseling approach for people with clinical depression: a study protocol for the Food for Mind randomized controlled trial.
Autorzy:
Roponen J; Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio Campus, Kuopio, Finland. .
Ruusunen A; Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio Campus, Kuopio, Finland.; Department of Psychiatry, Kuopio University Hospital, Kuopio, Finland.; Deakin University, Institute for Mental and Physical Health and Clinical Translation (IMPACT), Food & Mood Centre, School of Medicine, Geelong, Victoria, Australia.
Absetz P; Collaborative Care Systems Finland, Helsinki, Finland.
Partonen T; Finnish Institute for Health and Welfare (THL), Department of Public Health and Welfare, Helsinki, Finland.
Kuvaja-Köllner V; Faculty of Social Sciences and Business Studies, Department of Health and Social Management, University of Eastern Finland, Kuopio Campus, Kuopio, Finland.
Hujo M; Faculty of Science and Forestry, School of Computing, University of Eastern Finland, Kuopio Campus, Kuopio, Finland.
Nuutinen O; Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio Campus, Kuopio, Finland.
Pokaż więcej
Źródło:
Trials [Trials] 2021 May 17; Vol. 22 (1), pp. 344. Date of Electronic Publication: 2021 May 17.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Cognitive Behavioral Therapy*
Depressive Disorder, Major*
Cost-Benefit Analysis ; Depression/diagnosis ; Depression/therapy ; Humans ; Quality of Life ; Randomized Controlled Trials as Topic ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The circadian gene Cryptochrome 2 influences stress-induced brain activity and depressive-like behavior in mice.
Autorzy:
Sokolowska E; Molecular and Integrative Biosciences Research Program, University of Helsinki, Helsinki, Finland.
Viitanen R; Turku PET Centre, University of Turku, Turku, Finland.
Misiewicz Z; Molecular and Integrative Biosciences Research Program, University of Helsinki, Helsinki, Finland.; Department of Psychology and Logopedics, University of Helsinki, Helsinki, Finland.
Mennesson M; Molecular and Integrative Biosciences Research Program, University of Helsinki, Helsinki, Finland.; Department of Psychology and Logopedics, University of Helsinki, Helsinki, Finland.; SleepWell Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Saarnio S; Molecular and Integrative Biosciences Research Program, University of Helsinki, Helsinki, Finland.
Kulesskaya N; Molecular and Integrative Biosciences Research Program, University of Helsinki, Helsinki, Finland.
Kängsep S; Molecular and Integrative Biosciences Research Program, University of Helsinki, Helsinki, Finland.
Liljenbäck H; Turku PET Centre, University of Turku, Turku, Finland.; Turku Center for Disease Modeling, University of Turku, Turku, Finland.
Marjamäki P; Turku PET Centre, University of Turku, Turku, Finland.
Autio A; Turku PET Centre, University of Turku, Turku, Finland.
Callan SA; Molecular and Integrative Biosciences Research Program, University of Helsinki, Helsinki, Finland.
Nuutila P; Turku PET Centre, University of Turku, Turku, Finland.; Department of Endocrinology, Turku University Hospital, Turku, Finland.; Turku PET Centre, Turku University Hospital, Turku, Finland.
Roivainen A; Turku PET Centre, University of Turku, Turku, Finland.; Turku Center for Disease Modeling, University of Turku, Turku, Finland.; Turku PET Centre, Turku University Hospital, Turku, Finland.
Partonen T; Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland.
Hovatta I; Molecular and Integrative Biosciences Research Program, University of Helsinki, Helsinki, Finland.; Department of Psychology and Logopedics, University of Helsinki, Helsinki, Finland.; SleepWell Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland.; Neuroscience Center, Helsinki Institute of Life Science HiLIFE, University of Helsinki, Helsinki, Finland.
Pokaż więcej
Źródło:
Genes, brain, and behavior [Genes Brain Behav] 2021 Apr; Vol. 20 (4), pp. e12708. Date of Electronic Publication: 2020 Oct 26.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Anxiety/*genetics
Behavior, Animal/*physiology
Brain/*physiopathology
Circadian Rhythm/*genetics
Cryptochromes/*genetics
Animals ; Cryptochromes/metabolism ; Mice, Transgenic ; Suprachiasmatic Nucleus/metabolism ; Transcription Factors/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Population-level indicators associated with hormonal contraception use: a register-based matched case-control study.
Autorzy:
Toffol E; Department of Public Health, Clinicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland. .
Heikinheimo O; Department of Obstetrics and Gynaecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
But A; Department of Public Health, Clinicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Latvala A; Institute of Criminology and Legal Policy, University of Helsinki, Helsinki, Finland.
Partonen T; Mental Health Unit, Department of Public Health Solutions, Finnish Institute for Health and Welfare, Helsinki, Finland.
Haukka J; Department of Public Health, Clinicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Pokaż więcej
Źródło:
BMC public health [BMC Public Health] 2021 Mar 07; Vol. 21 (1), pp. 465. Date of Electronic Publication: 2021 Mar 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Contraception*
Hormonal Contraception*
Adolescent ; Adult ; Case-Control Studies ; Child ; Cities ; Female ; Finland/epidemiology ; Humans ; Middle Aged ; Sweden ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Development and implementation of guidelines for the management of depression: a systematic review.
Autorzy:
Lee Y; Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst St 9MP-325, Toronto, Ontario, Canada.
Brietzke E; Department of Psychiatry, Queen's University School of Medicine, Kingston, Canada.
Cao B; School of Psychology and Key Laboratory of Cognition and Personality, Southwest University, Chongqing, China.
Chen Y; Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Linnaranta O; Bipolar Disorders Clinic, Douglas Mental Health University Institute, Montréal, Canada.
Mansur RB; Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst St 9MP-325, Toronto, Ontario, Canada.
Cortes P; Pontificia Universidad Católica de Chile, Santiago, Región Metropolitana, Chile.
Kösters M; Department of Psychiatry II, Ulm University, Ulm, Germany.
Majeed A; Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst St 9MP-325, Toronto, Ontario, Canada.
Tamura JK; Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst St 9MP-325, Toronto, Ontario, Canada.
Lui LMW; Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst St 9MP-325, Toronto, Ontario, Canada.
Vinberg M; Psychiatric Research Unit, Psychiatric Centre North Zealand, Hilleroed, University Hospital of Copenhagen, Copenhagen, Denmark.
Keinänen J; Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland.
Kisely S; School of Clinical Medicine, The University of Queensland, Brisbane, Australia.
Naveed S; Department of Psychiatry and Behavioral Sciences, University of Kansas Medical Center, Kansas, USA.
Barbui C; WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Biomedicine and Movement Sciences, Verona, Italy.
Parker G; Global Alliance for Chronic Diseases, Wellcome Trust, London, England.
Owolabi M; Center for Genomics and Precision Medicine, University of Ibadan, Ibadan, Nigeria.
Nishi D; Department of Mental Health, The University of Tokyo, Tokyo, Japan.
Lee J; Paik Institute for Clinical Research, Inje University, Busan, Republic of Korea.
Srisurapanont M; Department of Psychiatry, Chiang Mai University, Chiang Mai, Thailand.
Gill H; Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst St 9MP-325, Toronto, Ontario, Canada.
Guo L; School of Public Health, Sun Yat-sen University, Guangdong, China.
Balanzá-Martínez V; Teaching Unit of Psychiatry and Psychological Medicine, University of Valencia, Valencia, CIBERSAM, Spain.
Partonen T; Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland.
Nolen WA; Department of Psychiatry, University of Groningen, Groningen, Netherlands.
Lee JH; Department of Psychiatry, Gyeongsang National University Hospital, Jinju, Republic of Korea.
Kim JH; Paik Institute for Clinical Research, Inje University, Busan, Republic of Korea.
Chavannes NH; Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.
Ewais T; School of Clinical Medicine, The University of Queensland, Brisbane, Australia.
Atienza-Carbonell B; Medical School, University of Valencia, Valencia, Spain.
Silven AV; Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.
Yasuma N; Department of Mental Health, The University of Tokyo, Tokyo, Japan.
Gil A; WHO European Office for the Prevention and Control of Noncommunicable Diseases, Division of Country Health Programme, Moscow, Russian Federation.
Novikov A; Psychiatric and Neurological Hospital, Surgut, Russian Federation.
Lacey C; Maori Indigenous Health Institute, University of Otago, Christchurch, New Zealand.
Versluis A; Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.
von Malortie S; The National Board of Health and Welfare, Stockholm, Sweden.
Chan LF; Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst St 9MP-325, Toronto, Ontario, Canada.; Department of Psychiatry, Queen's University School of Medicine, Kingston, Canada.
Waqas A; Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst St 9MP-325, Toronto, Ontario, Canada.; School of Psychology and Key Laboratory of Cognition and Personality, Southwest University, Chongqing, China.
Purgato M; WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Biomedicine and Movement Sciences, Verona, Italy.
Aardoom JJ; Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.
Ly-Uson JT; Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst St 9MP-325, Toronto, Ontario, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Sim K; Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst St 9MP-325, Toronto, Ontario, Canada.; Bipolar Disorders Clinic, Douglas Mental Health University Institute, Montréal, Canada.
Tuineag M; Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst St 9MP-325, Toronto, Ontario, Canada.; Pontificia Universidad Católica de Chile, Santiago, Región Metropolitana, Chile.
van der Kleij RMJJ; Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.
van Luenen S; Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.
Suttajit S; Department of Psychiatry, Chiang Mai University, Chiang Mai, Thailand.
Hajek T; Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst St 9MP-325, Toronto, Ontario, Canada.; Department of Psychiatry II, Ulm University, Ulm, Germany.
Lee YW; Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst St 9MP-325, Toronto, Ontario, Canada.; Bipolar Disorders Clinic, Douglas Mental Health University Institute, Montréal, Canada.
Porter RJ; Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst St 9MP-325, Toronto, Ontario, Canada.; Psychiatric Research Unit, Psychiatric Centre North Zealand, Hilleroed, University Hospital of Copenhagen, Copenhagen, Denmark.
Alsuwaidan M; Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst St 9MP-325, Toronto, Ontario, Canada.; Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland.
Rosenblat JD; Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst St 9MP-325, Toronto, Ontario, Canada.; School of Clinical Medicine, The University of Queensland, Brisbane, Australia.
Ravindran AV; Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst St 9MP-325, Toronto, Ontario, Canada.; School of Clinical Medicine, The University of Queensland, Brisbane, Australia.
Lam RW; Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst St 9MP-325, Toronto, Ontario, Canada.; Department of Psychiatry and Behavioral Sciences, University of Kansas Medical Center, Kansas, USA.
McIntyre RS; Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst St 9MP-325, Toronto, Ontario, Canada.
Pokaż więcej
Corporate Authors:
Global Alliance for Chronic Diseases (GACD) Mental Health Guidelines Working Group
Źródło:
Bulletin of the World Health Organization [Bull World Health Organ] 2020 Oct 01; Vol. 98 (10), pp. 683-697H. Date of Electronic Publication: 2020 Aug 27.
Typ publikacji:
Journal Article; Review; Systematic Review
MeSH Terms:
Depression*/therapy
Depressive Disorder, Major*
Adult ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Diagnostic conversion from unipolar depression to bipolar disorder, schizophrenia, or schizoaffective disorder: A nationwide prospective 15-year register study on 43 495 inpatients.
Autorzy:
Baryshnikov I; Department of Psychiatry, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Sund R; Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
Marttunen M; Unit of Adolescent Psychiatry, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Svirskis T; Department of Psychiatry, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Partonen T; Mental Health Unit, Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland.
Pirkola S; Mental Health Unit, Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland.; Faculty of Social Sciences, University of Tampere and Pirkanmaa Hospital District, Tampere, Finland.
Isometsä ET; Department of Psychiatry, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Mental Health Unit, Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland.
Pokaż więcej
Źródło:
Bipolar disorders [Bipolar Disord] 2020 Sep; Vol. 22 (6), pp. 582-592. Date of Electronic Publication: 2020 May 22.
Typ publikacji:
Journal Article
MeSH Terms:
Bipolar Disorder/*diagnosis
Depressive Disorder, Major/*diagnosis
Psychotic Disorders/*diagnosis
Schizophrenia/*diagnosis
Adult ; Bipolar Disorder/psychology ; Cohort Studies ; Depressive Disorder, Major/psychology ; Disease Progression ; Female ; Hospitalization ; Humans ; Inpatients ; Male ; Middle Aged ; Prospective Studies ; Psychotic Disorders/psychology ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Ultraviolet B radiation modifies circadian time in epidermal skin and in subcutaneous adipose tissue.
Autorzy:
Nikkola V; Department of Dermatology and Venereology, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.; Department of Dermatology and Allergology, Tampere University Hospital, Tampere, Finland.; Department of Dermatology and Allergology, Päijät-Häme Social and Health Care Group, Lahti, Finland.
Miettinen ME; Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland.
Karisola P; Department of Bacteriology and Immunology, Faculty of Medicine, Medicum, University of Helsinki, Helsinki, Finland.
Grönroos M; Department of Dermatology and Allergology, Päijät-Häme Social and Health Care Group, Lahti, Finland.
Ylianttila L; STUK - Radiation and Nuclear Safety Authority, Helsinki, Finland.
Alenius H; Department of Bacteriology and Immunology, Faculty of Medicine, Medicum, University of Helsinki, Helsinki, Finland.; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Snellman E; Department of Dermatology and Venereology, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.; Department of Dermatology and Allergology, Tampere University Hospital, Tampere, Finland.
Partonen T; Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland.
Pokaż więcej
Źródło:
Photodermatology, photoimmunology & photomedicine [Photodermatol Photoimmunol Photomed] 2019 May; Vol. 35 (3), pp. 157-163. Date of Electronic Publication: 2018 Dec 10.
Typ publikacji:
Journal Article
MeSH Terms:
Cryptochromes/*biosynthesis
Gene Expression Regulation/*radiation effects
Skin/*metabolism
Subcutaneous Fat/*metabolism
Ultraviolet Rays/*adverse effects
Adult ; Female ; Humans ; Male ; RNA, Messenger/biosynthesis ; Skin/pathology ; Subcutaneous Fat/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Non-medical use of psychoactive prescription drugs is associated with fatal poisoning.
Autorzy:
Haukka J; Department of Public Health, University of Helsinki, Helsinki, Finland.
Kriikku P; Forensic Toxicology Unit, National Institute for Health and Welfare, Helsinki, Finland.; Department of Forensic Medicine, University of Helsinki, Helsinki, Finland.
Mariottini C; Department of Forensic Medicine, University of Helsinki, Helsinki, Finland.
Partonen T; Department of Health, National Institute for Health and Welfare, Helsinki, Finland.
Ojanperä I; Forensic Toxicology Unit, National Institute for Health and Welfare, Helsinki, Finland.; Department of Forensic Medicine, University of Helsinki, Helsinki, Finland.
Pokaż więcej
Źródło:
Addiction (Abingdon, England) [Addiction] 2018 Mar; Vol. 113 (3), pp. 464-472. Date of Electronic Publication: 2017 Sep 28.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Misuse/*mortality
Drug Misuse/*statistics & numerical data
Drug Overdose/*epidemiology
Psychotropic Drugs/*poisoning
Adult ; Age Factors ; Blood Alcohol Content ; Cohort Studies ; Female ; Finland/epidemiology ; Humans ; Male ; Middle Aged ; Prescription Drugs ; Registries ; Retrospective Studies ; Sex Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A genome-wide screen for acrophobia susceptibility loci in a Finnish isolate.
Autorzy:
Misiewicz Z; Department of Biosciences, University of Helsinki, Helsinki, Finland.
Hiekkalinna T; Department of Health, National Institute for Health and Welfare, Helsinki, Finland.; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.
Paunio T; Department of Health, National Institute for Health and Welfare, Helsinki, Finland.; Department of Psychiatry, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Development of Work and Work Organizations, Finnish Institute of Occupational Health, Helsinki, Finland.
Varilo T; Department of Medical Genetics, University of Helsinki, Helsinki, Finland.
Terwilliger JD; Department of Health, National Institute for Health and Welfare, Helsinki, Finland.; Department of Psychiatry, Department of Genetics and Development, and Gertrude H. Sergievsky Center, Columbia University, New York NY, USA.; Division of Medical Genetics, New York State Psychiatric Institute, New York NY, USA.
Partonen T; Department of Health, National Institute for Health and Welfare, Helsinki, Finland.
Hovatta I; Department of Biosciences, University of Helsinki, Helsinki, Finland.; Department of Health, National Institute for Health and Welfare, Helsinki, Finland.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2016 Dec 20; Vol. 6, pp. 39345. Date of Electronic Publication: 2016 Dec 20.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Anticipation, Psychological/*physiology
Genetic Predisposition to Disease/*genetics
Genome-Wide Association Study/*methods
Phobic Disorders/*genetics
Alleles ; Chromosome Mapping ; Female ; Finland ; Genetic Linkage/genetics ; Haplotypes/genetics ; Humans ; Male ; Microsatellite Repeats/genetics ; Pedigree ; Polymorphism, Single Nucleotide/genetics ; Schizophrenia/genetics
SCR Disease Name:
Phobia, Specific
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Brief Behavioral Sleep Intervention for Adolescents: An Effectiveness Study.
Autorzy:
Paavonen EJ; a Department of Health National Institute for Health and Welfare , Helsinki , Finland.; b Child Psychiatry University of Helsinki and Helsinki University Hospital , Finland.
Huurre T; a Department of Health National Institute for Health and Welfare , Helsinki , Finland.; c Department of Health and Social Welfare , City of Vantaa , Finland.
Tilli M; d Department of Education City of Vantaa , Finland.
Kiviruusu O; a Department of Health National Institute for Health and Welfare , Helsinki , Finland.
Partonen T; a Department of Health National Institute for Health and Welfare , Helsinki , Finland.
Pokaż więcej
Źródło:
Behavioral sleep medicine [Behav Sleep Med] 2016 Jul-Aug; Vol. 14 (4), pp. 351-66. Date of Electronic Publication: 2015 Sep 17.
Typ publikacji:
Clinical Trial; Journal Article
MeSH Terms:
Behavior Therapy*
Sleep/*physiology
Sleep Initiation and Maintenance Disorders/*psychology
Sleep Initiation and Maintenance Disorders/*therapy
Adolescent ; Anxiety/psychology ; Anxiety/therapy ; Female ; Humans ; Male ; Schools ; Self Report ; Sleep Initiation and Maintenance Disorders/diagnosis ; Stress, Psychological/psychology ; Stress, Psychological/therapy ; Students/psychology ; Time Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts.
Autorzy:
Schwantes-An TH; Department of Genetics, Washington University School of Medicine, 4523 Clayton Avenue, Campus Box 8232, St. Louis, MO, 63110, USA.; Genometrics Section, Computational and Statistical Genomics Branch, Division of Intramural Research, National Human Genome Research Institute, US National Institutes of Health (NIH), Baltimore, MD, 21224, USA.
Zhang J; Department of Genetics, Washington University School of Medicine, 4523 Clayton Avenue, Campus Box 8232, St. Louis, MO, 63110, USA.; Key Laboratory of Brain Function and Disease, School of Life Sciences, Chinese Academy of Sciences, University of Science and Technology of China, Hefei, Anhui, 230026, China.
Chen LS; Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Hartz SM; Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Culverhouse RC; Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Chen X; Department of Psychiatry, Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, VA, 23298, USA.
Coon H; Department of Psychiatry, University of Utah School of Medicine, Salt Lake City, UT, 84108, USA.
Frank J; Department of Genetic Epidemiology in Psychiatry, Medical Faculty Mannheim, Central Institute of Mental Health, Heidelberg University, 68159, Mannheim, Germany.
Kamens HM; Institute for Behavioral Genetics, University of Colorado, Boulder, CO, 80309, USA.; Department of Integrative Physiology, University of Colorado, Boulder, CO, 80309, USA.; Department of Biobehavioral Health, The Pennsylvania State University, University Park, PA, 16802, USA.
Konte B; Department of Psychiatry, Universitätsklinikum Halle (Saale), 06112, Halle (Saale), Germany.
Kovanen L; Department of Mental Health and Substance Abuse Services, National Institute for Health and Welfare, Helsinki, 00271, Finland.
Latvala A; Department of Public Health, University of Helsinki, Helsinki, 00014, Finland.
Legrand LN; Department of Psychology, University of Minnesota, Minneapolis, MN, 55455, USA.
Maher BS; Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, 21205, USA.
Melroy WE; Institute for Behavioral Genetics, University of Colorado, Boulder, CO, 80309, USA.; Department of Integrative Physiology, University of Colorado, Boulder, CO, 80309, USA.
Nelson EC; Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Reid MW; Oregon Research Institute, Eugene, OR, 97403, USA.
Robinson JD; Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Shen PH; Section of Human Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, 20892, USA.
Yang BZ; Department of Psychiatry, Yale University, New Haven, CT, 06516, USA.
Andrews JA; Oregon Research Institute, Eugene, OR, 97403, USA.
Aveyard P; Department of Primary Care Health Sciences, University of Oxford, Oxford, OX2 6GG, United Kingdom.
Beltcheva O; Department of Medical Chemistry and Biochemistry, Molecular Medicine Center, Medical University-Sofia, 1431, Sofia, Bulgaria.
Brown SA; Department of Psychiatry, University of California San Diego, La Jolla, CA, 92093, USA.
Cannon DS; Department of Psychiatry, University of Utah School of Medicine, Salt Lake City, UT, 84108, USA.
Cichon S; Department. of Genomics, Life and Brain Center, Institute of Human Genetics, University of Bonn, Bonn, 53127, Germany.; Division of Medical Genetics, Department of Biomedicine, University Hospital Basel, University of Basel, Basel, 4003, Switzerland.
Corley RP; Institute for Behavioral Genetics, University of Colorado, Boulder, CO, 80309, USA.
Dahmen N; Ökumenisches Hainich-Klinikum, Mühlhausen/Thüringen, Germany.
Degenhardt L; National Drug and Alcohol Research Centre, University of New South Wales, Randwick, NSW, 2031, Australia.; School of Population and Global Health, University of Melbourne, Melbourne, 3010, Australia.
Foroud T; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
Gaebel W; University of Düsseldorf, 40225, Düsseldorf, Germany.
Giegling I; Department of Psychiatry, Universitätsklinikum Halle (Saale), 06112, Halle (Saale), Germany.
Glatt SJ; Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Grucza RA; Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Hardin J; Center for Health Sciences, Biosciences Division, SRI International, Menlo Park, CA, 94025, USA.
Hartmann AM; Department of Psychiatry, Universitätsklinikum Halle (Saale), 06112, Halle (Saale), Germany.
Heath AC; Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Herms S; Department. of Genomics, Life and Brain Center, Institute of Human Genetics, University of Bonn, Bonn, 53127, Germany.; Division of Medical Genetics, Department of Biomedicine, University Hospital Basel, University of Basel, Basel, 4003, Switzerland.
Hodgkinson CA; Section of Human Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, 20892, USA.
Hoffmann P; Department. of Genomics, Life and Brain Center, Institute of Human Genetics, University of Bonn, Bonn, 53127, Germany.; Division of Medical Genetics, Department of Biomedicine, University Hospital Basel, University of Basel, Basel, 4003, Switzerland.
Hops H; Oregon Research Institute, Eugene, OR, 97403, USA.
Huizinga D; Institute of Behavioral Science, University of Colorado, Boulder, CO, 80309, USA.
Ising M; Max-Planck-Institute of Psychiatry, 80804, Munich, Germany.
Johnson EO; Behavioral Health Research Division, Research Triangle Institute International, Durham, NC, 27709, USA.
Johnstone E; Department of Oncology, University of Oxford, Oxford, OX3 7DQ, United Kingdom.
Kaneva RP; Department of Medical Chemistry and Biochemistry, Molecular Medicine Center, Medical University-Sofia, 1431, Sofia, Bulgaria.
Kendler KS; Department of Psychiatry, Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, VA, 23298, USA.
Kiefer F; Department of Addictive Behavior and Addiction Medicine, Medical Faculty Mannheim, Central Institute of Mental Health, Heidelberg University, 68159, Mannheim, Germany.
Kranzler HR; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Krauter KS; Institute for Behavioral Genetics, University of Colorado, Boulder, CO, 80309, USA.; Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, CO, 80309, USA.
Levran O; Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, 10065, USA.
Lucae S; Max-Planck-Institute of Psychiatry, 80804, Munich, Germany.
Lynskey MT; Addictions Department, Institute of Psychiatry, King's College London, London, SE5 8BB, UK.
Maier W; University of Bonn, 53113, Bonn, Germany.
Mann K; Medical Faculty Mannheim, Central Institute of Mental Health, Heidelberg University, 68159, Mannheim, Germany.
Martin NG; Department of Genetic Epidemiology, Queensland Institute of Medical Research, Brisbane, QLD, 4029, Australia.
Mattheisen M; Department. of Genomics, Life and Brain Center, Institute of Human Genetics, University of Bonn, Bonn, 53127, Germany.; Harvard School of Public Health, Boston, MA, 02115, USA.; Aarhus University, Aarhus, 8000, Denmark.
Montgomery GW; Department of Genetic Epidemiology, Queensland Institute of Medical Research, Brisbane, QLD, 4029, Australia.
Müller-Myhsok B; Max-Planck-Institute of Psychiatry, 80804, Munich, Germany.
Murphy MF; Childhood Cancer Research Group, University of Oxford, Oxford, OX3 7LG, UK.
Neale MC; Department of Psychiatry, Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, VA, 23298, USA.
Nikolov MA; Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, 63110, USA.; Department of Medical Chemistry and Biochemistry, Molecular Medicine Center, Medical University-Sofia, 1431, Sofia, Bulgaria.
Nishita D; Center for Health Sciences, Biosciences Division, SRI International, Menlo Park, CA, 94025, USA.
Nöthen MM; Department. of Genomics, Life and Brain Center, Institute of Human Genetics, University of Bonn, Bonn, 53127, Germany.
Nurnberger J; Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
Partonen T; Department of Mental Health and Substance Abuse Services, National Institute for Health and Welfare, Helsinki, 00271, Finland.
Pergadia ML; Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Reynolds M; Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA, 15213, USA.
Ridinger M; Department of Psychiatry, University Medical Center Regensburg, University of Regensburg, 8548, Regensburg, Germany.; Psychiatric Hospital, Konigsfelden, Windisch, Switzerland.
Rose RJ; Department of Psychological and Brain Sciences, Indiana University, Bloomington, IN, 47405, USA.
Rouvinen-Lagerström N; Department of Mental Health and Substance Abuse Services, National Institute for Health and Welfare, Helsinki, 00271, Finland.
Scherbaum N; Addiction Research Group at the Department of Psychiatry and Psychotherapy, LVR Hospital Essen, University of Duisburg-Essen, 45147, Essen, Germany.
Schmäl C; Medical Faculty Mannheim, Central Institute of Mental Health, Heidelberg University, 68159, Mannheim, Germany.
Soyka M; Department of Psychiatry, University of Munich, 3860, Munich, Germany.; Private Hospital Meiringen, Meiringen, Switzerland.
Stallings MC; Institute for Behavioral Genetics, University of Colorado, Boulder, CO, 80309, USA.; Department of Psychology & Neuroscience, University of Colorado, Boulder, CO, 80309, USA.
Steffens M; Research Department, Federal Institute for Drugs and Medical Devices (BfArM), Kurt-Georg-Kiesinger-Allee 3, 53175, Bonn, Germany.
Treutlein J; Department of Genetic Epidemiology in Psychiatry, Medical Faculty Mannheim, Central Institute of Mental Health, Heidelberg University, 68159, Mannheim, Germany.
Tsuang M; Department of Psychiatry, University of California San Diego, La Jolla, CA, 92093, USA.
Wall TL; Department of Psychiatry, University of California San Diego, La Jolla, CA, 92093, USA.
Wodarz N; Department of Psychiatry, University Medical Center Regensburg, University of Regensburg, 8548, Regensburg, Germany.
Yuferov V; Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, 10065, USA.
Zill P; University of Munich, Munich, Germany.
Bergen AW; Center for Health Sciences, Biosciences Division, SRI International, Menlo Park, CA, 94025, USA.
Chen J; Department of Psychiatry, Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, VA, 23298, USA.
Cinciripini PM; Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Edenberg HJ; Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
Ehringer MA; Institute for Behavioral Genetics, University of Colorado, Boulder, CO, 80309, USA.; Department of Integrative Physiology, University of Colorado, Boulder, CO, 80309, USA.
Ferrell RE; Department of Human Genetics, University of Pittsburgh, Pittsburgh, PA, 15261, USA.
Gelernter J; Department of Psychiatry, Yale University, New Haven, CT, 06516, USA.; Department of Genetics, Yale University, New Haven, CT, 06516, USA.; Department of Neurobiology, Yale University, New Haven, CT, 06516, USA.
Goldman D; Section of Human Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, 20892, USA.
Hewitt JK; Institute for Behavioral Genetics, University of Colorado, Boulder, CO, 80309, USA.; Department of Psychology & Neuroscience, University of Colorado, Boulder, CO, 80309, USA.
Hopfer CJ; Department of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
Iacono WG; Department of Psychology, University of Minnesota, Minneapolis, MN, 55455, USA.
Kaprio J; Department of Mental Health and Substance Abuse Services, National Institute for Health and Welfare, Helsinki, 00271, Finland.; Department of Public Health, University of Helsinki, Helsinki, 00014, Finland.; Institute for Molecular Medicine FIMM, University of Helsinki, 00014, Helsinki, Finland.
Kreek MJ; Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, 10065, USA.
Kremensky IM; Department of Medical Chemistry and Biochemistry, Molecular Medicine Center, Medical University-Sofia, 1431, Sofia, Bulgaria.
Madden PA; Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, 63110, USA.
McGue M; Department of Psychology, University of Minnesota, Minneapolis, MN, 55455, USA.
Munafò MR; MRC Integrative Epidemiology Unit, UK Centre for Tobacco and Alcohol Studies, and School of Experimental Psychology, University of Bristol, Bristol, BS8 1TU, UK.
Philibert RA; Department of Psychiatry, University of Iowa, Iowa City, IA, 52242, USA.
Rietschel M; Department of Genetic Epidemiology in Psychiatry, Medical Faculty Mannheim, Central Institute of Mental Health, Heidelberg University, 68159, Mannheim, Germany.
Roy A; Psychiatry Service, Department of Veteran Affairs, New Jersey VA Health Care System, East Orange, NJ, 07018, USA.
Rujescu D; Department of Psychiatry, Universitätsklinikum Halle (Saale), 06112, Halle (Saale), Germany.
Saarikoski ST; Department of Mental Health and Substance Abuse Services, National Institute for Health and Welfare, Helsinki, 00271, Finland.
Swan GE; Department of Medicine, Stanford Prevention Research Center, Stanford University School of Medicine, Stanford, CA, 94304, USA.
Todorov AA; Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Vanyukov MM; Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA, 15213, USA.
Weiss RB; Department of Human Genetics, University of Utah School of Medicine, Salt Lake City, UT, 84112, USA.
Bierut LJ; Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Saccone NL; Department of Genetics, Washington University School of Medicine, 4523 Clayton Avenue, Campus Box 8232, St. Louis, MO, 63110, USA. .
Pokaż więcej
Źródło:
Behavior genetics [Behav Genet] 2016 Mar; Vol. 46 (2), pp. 151-69. Date of Electronic Publication: 2015 Sep 21.
Typ publikacji:
Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Genetic Association Studies*
Genetic Predisposition to Disease*
Polymorphism, Single Nucleotide/*genetics
Receptors, Opioid, mu/*genetics
Substance-Related Disorders/*genetics
White People/*genetics
Adolescent ; Adult ; Alleles ; Case-Control Studies ; Child ; Cohort Studies ; Gene Frequency/genetics ; Humans ; Male ; Sample Size
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Eveningness relates to burnout and seasonal sleep and mood problems among young adults.
Autorzy:
Merikanto I; a Ilona Merikanto, Department of Mental Health and Substance Abuse Services , National Institute for Health and Welfare , Helsinki , Finland , Department of Biosciences , University of Helsinki , Helsinki , Finland.
Suvisaari J; b Jaana Suvisaari, Department of Mental Health and Substance Abuse Services , National Institute for Health and Welfare , Helsinki , Finland.
Lahti T; c Tuuli Lahti, Department of Mental Health and Substance Abuse Services , National Institute for Health and Welfare , Helsinki , Finland , Department of Behavioural Sciences and Philosophy , University of Turku , Turku , Finland.
Partonen T; d Timo Partonen, Department of Mental Health and Substance Abuse Services , National Institute for Health and Welfare , Helsinki , Finland.
Pokaż więcej
Źródło:
Nordic journal of psychiatry [Nord J Psychiatry] 2016; Vol. 70 (1), pp. 72-80. Date of Electronic Publication: 2015 Jun 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Circadian Rhythm/*physiology
Seasonal Affective Disorder/*physiopathology
Sleep Wake Disorders/*physiopathology
Stress, Psychological/*physiopathology
Adolescent ; Adult ; Diagnostic and Statistical Manual of Mental Disorders ; Female ; Finland/epidemiology ; Humans ; Male ; Seasonal Affective Disorder/epidemiology ; Seasons ; Sleep Wake Disorders/epidemiology ; Stress, Psychological/epidemiology ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Interrelationships of Physical Activity and Sleep with Cardiovascular Risk Factors: a Person-Oriented Approach.
Autorzy:
Wennman H; National Institute for Health and Welfare, P.O. Box 30, 00271, Helsinki, Finland. .
Kronholm E; National Institute for Health and Welfare, P.O. Box 30, 00271, Helsinki, Finland. .
Partonen T; National Institute for Health and Welfare, P.O. Box 30, 00271, Helsinki, Finland. timo.partonen@thl.fi.
Tolvanen A; University of Jyväskylä, P.O. Box 35, 40014, Jyväskylä, Finland. .
Peltonen M; National Institute for Health and Welfare, P.O. Box 30, 00271, Helsinki, Finland. .
Vasankari T; National Institute for Health and Welfare, P.O. Box 30, 00271, Helsinki, Finland. .; UKK-Institute for Health Promotion and Research, P.O. Box 30, 33501, Tampere, Finland. .
Borodulin K; National Institute for Health and Welfare, P.O. Box 30, 00271, Helsinki, Finland. .
Pokaż więcej
Źródło:
International journal of behavioral medicine [Int J Behav Med] 2015 Dec; Vol. 22 (6), pp. 735-47.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cardiovascular Diseases*/epidemiology
Cardiovascular Diseases*/psychology
Motor Activity/*physiology
Sleep/*physiology
Adult ; Aged ; Cross-Sectional Studies ; Exercise/physiology ; Exercise/psychology ; Female ; Health Behavior ; Humans ; Male ; Metabolism ; Middle Aged ; Risk Factors ; Sedentary Behavior ; Surveys and Questionnaires
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 66

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies